Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2026-05-25 Major Shareholding Noti…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 92% confidence The document is a notification filed under Swedish Finansinspektionen rules detailing a change in a major shareholder’s holdings of Vivesto AB shares, including before and after share counts and voting rights, and explicitly states 'Reason for major shareholding notification'. This matches the Major Shareholding Notification category.
2026-05-25 English
Vivesto offentliggör tidplan för sammanläggning av aktier
Share Issue/Capital Change Classification · 91% confidence The document is a press release announcing a 1:100 share consolidation (capital change) with details on the record date, trading dates, and new ISIN – it is an announcement of a capital change (share consolidation). This clearly falls under Share Issue/Capital Change.
2026-05-13 Swedish
Vivesto announces timetable for reverse share split
Share Issue/Capital Change Classification · 11% confidence The document is a press release announcing the timetable for a reverse share split (1:100), detailing record dates, ISIN change, and effects on share capital. This is a capital structure change. According to the definitions, announcements of stock splits or capital changes fall under “Share Issue/Capital Change” (SHA). It is not a financing update or regulatory filing announcement; it is a direct capital change announcement itself.
2026-05-13 English
Kommuniké från årsstämma i Vivesto AB
AGM Information Classification · 95% confidence The document is a press release dated May 7, 2026, detailing decisions made at the Annual General Meeting (AGM) of Vivesto AB. It includes resolutions on approval of financial statements, discharge of liability for board members and CEO, election of board members and auditors, remuneration decisions, amendments to the articles of association including share consolidation and capital reduction, and authorization for the board to issue shares and financial instruments. The content is typical of AGM meeting minutes or a communiqué summarizing AGM decisions. It is not the full Annual Report (10-K) or Interim Report (IR), nor is it a proxy statement or voting results announcement. The document is a communication of AGM decisions, which fits the category AGM Information (AGM-R). The document length (7225 characters) and detailed content support this classification with high confidence.
2026-05-07 English
Report from Annual General Meeting in Vivesto AB
AGM Information Classification · 100% confidence The document is a press release dated 7 May 2026 reporting on the resolutions passed at the Annual General Meeting (AGM) of Vivesto AB. It includes details on adoption of financial statements, discharge of liability, election of board members and auditor, fees, amendments to articles of association, reverse share split, share capital reduction, and authorization for share issues. The content is typical of AGM meeting minutes or summary of resolutions rather than the full annual report or financial statements. The document is over 8,000 characters and contains substantive information about the AGM decisions, not just an announcement of a report. Therefore, it fits the category of AGM Information (AGM-R).
2026-05-07 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport januari - mars 2026' which translates to 'Interim Report January - March 2026'. It covers detailed financial and operational performance for the first quarter of 2026, including revenue, operating results, cash position, and business updates. The length is about 15,000 characters, indicating a full report rather than a brief announcement. It contains substantive financial data and management commentary on business progress and outlook. The document is not a brief announcement of report publication, nor a certification or regulatory filing. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.